Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Meryl Comer, UsAgainstAlzheimer's and Meryl Comer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Meryl Comer, UsAgainstAlzheimer's and Meryl Comer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep 99: The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

16:32
 
Share
 

Manage episode 522248416 series 41856
Content provided by Meryl Comer, UsAgainstAlzheimer's and Meryl Comer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Meryl Comer, UsAgainstAlzheimer's and Meryl Comer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

BrainStorm wants to hear from you! Send us a text.

Ep 99: The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials. Dwyer shares how the field is shifting toward earlier intervention and leveraging artificial intelligence to improve trial efficiency and accuracy. AI can help identify subtle disease patterns and ensure trials enroll appropriate candidates. GAP is also pioneering remote, decentralized trials that bring research into patients' homes rather than requiring frequent clinic visits, aiming to dramatically scale up participation.

Dwyer also highlights proven lifestyle interventions that support cognitive health alongside pharmaceutical treatments and suggests multiple treatment approaches may soon be available.

This episode of BrainStorm is sponsored by Johnson & Johnson

Support the show

  continue reading

60 episodes

Artwork
iconShare
 
Manage episode 522248416 series 41856
Content provided by Meryl Comer, UsAgainstAlzheimer's and Meryl Comer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Meryl Comer, UsAgainstAlzheimer's and Meryl Comer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

BrainStorm wants to hear from you! Send us a text.

Ep 99: The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials. Dwyer shares how the field is shifting toward earlier intervention and leveraging artificial intelligence to improve trial efficiency and accuracy. AI can help identify subtle disease patterns and ensure trials enroll appropriate candidates. GAP is also pioneering remote, decentralized trials that bring research into patients' homes rather than requiring frequent clinic visits, aiming to dramatically scale up participation.

Dwyer also highlights proven lifestyle interventions that support cognitive health alongside pharmaceutical treatments and suggests multiple treatment approaches may soon be available.

This episode of BrainStorm is sponsored by Johnson & Johnson

Support the show

  continue reading

60 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play